Download Guidelines For High Risk Neonatal Hearing Screening

Buku NHS Edition:Layout 1
10/16/09
3:11 PM
Page 1
Buku NHS Edition:Layout 1
10/16/09
3:11 PM
Page 2
Guidelines For High Risk Neonatal Hearing Screening
These guidelines was developed by the Surgical and Emergency Medical Services
Unit, Medical Services Development Section of Medical Development Division
and the Drafting Committee.
Published in August 2009
A catalogue record of this document is available from the Library and Resource
Unit, Institute for Medical Research, Ministry of Health;
MOH/P/PAK/182.09 (GU)
All copyrights reserved
2
Buku NHS Edition:Layout 1
10/16/09
3:11 PM
Page 3
Guidelines For High Risk Neonatal Hearing Screening
ACKNOWLEDGEMENT
Surgical and Emergency Services Unit, Medical Development would like to
acknowledge the contributions of the Drafting Committee headed by Wan
Shuhailah bt Wan Husain, Audiologist, Hospital Sultanah Nur Zahirah, Kuala
Terengganu and other audiologists for their commitment and dedication towards
the development of this document.
Special gratitude to Mr Abd Majid Mohd Nasir as the National Advisor of ORL
Surgery for his leadership, guidance and continuing support in developing this
document.
3
Buku NHS Edition:Layout 1
10/16/09
3:11 PM
Page 4
Guidelines For High Risk Neonatal Hearing Screening
TABLE OF CONTENTS
PAGE
FOREWORD
Deputy Director General of Health (Medical)
ARTICLES
List of Abbreviations
1.0
2.0
3.0
4.0
5.0
6.0
7.0
8.0
Introduction
Definition
Objective
Roles and responsibilities
Methodology
Training for screening personnel
Management
Program evaluation and monitoring
APPENDIX 1
6
7
8
8
9
15
17
18
19
High Risk Register
21
Flowchart for High Risk Neonatal Hearing Screening
23
Work Process of High Risk Neonatal Hearing Screening
24
High Risk Neonatal Hearing Screening
26
APPENDIX 2
APPENDIX 3
APPENDIX 4
REFERENCES
DRAFTING COMMITTEE
4
5
27
28
Buku NHS Edition:Layout 1
10/16/09
3:11 PM
Page 5
Guidelines For High Risk Neonatal Hearing Screening
FOREWORD BY
DEPUTY DIRECTOR GENERAL MINISTRY OF HEALTH MALAYSIA
(MEDICAL)
Good hearing is essential for a child’s overall development. Hearing loss is one of
the most common birth defect. Approximately 3 out of 1,000 babies are born with
significant hearing loss. If a child’s hearing loss goes undetected at birth, it can
result in delays in language and social development. Early intervention greatly
improves the child’s prognosis of achieving normal social, emotional and language
development.
These guidelines will guide health care professionals working towards attaining the
highest professional standards in the field of newborn hearing screening. In
addition they address the issues of the resources, trained and credentialed
personnel and organizational structure needed to run the screening as a national
program.
I believe that with the adoption of these guidelines, the High Risk Neonatal Hearing
Screening Program will develop into a Universal Screening for all the newborns in
our country. This will contribute significantly towards a healthy nation.
The Ministry recognizes the commitment and support given by the members of
the committee for the development of GUIDELINES FOR HIGH RISK NEONATAL
HEARING SCREENING. Special gratitude to all other parties who have directly
or indirectly contributed to the successful publication of this document.
Datuk Dr. Noor Hisham B Abdullah
Deputy Director General of Health (Medical)
Ministry Of Health Malaysia
August 2009
5
Buku NHS Edition:Layout 1
10/16/09
3:11 PM
Page 6
Guidelines For High Risk Neonatal Hearing Screening
LIST OF ABBREVIATIONS
AABR
ABR
B/O
CMV
dBnHL
Automated Auditory Brainstem Response
Auditory Brainstem Response
Baby of
Cytomegalovirus
Decibel (norms) Hearing Level
DOB
Date of birth
KPI
Key Performance Indicator
HRNHS
MOH
High Risk Newborn Hearing Screening
Ministry of Health
NICU
Neonatal Intensive Care Unit
ORL
Otorhinolaryngology
OAE
SCN
6
Otoacoustic Emission
Special Care Nursery
Buku NHS Edition:Layout 1
10/16/09
3:11 PM
Page 7
Guidelines For High Risk Neonatal Hearing Screening
INTRODUCTION
1.0
Hearing loss is one of the most common major abnormalities present
at birth and, if undetected, will impair speech, language and cognitive
development. The prevalence of high risk babies with hearing loss is
estimated at 2 to 4 per 100 infant in the intensive care unit.
The critical period for language and speech development is generally
regarded as the first 3 years of life. Children who are identified with hearing
loss between birth and 6 months of age and have received immediate
intervention (amplification, medical referral, family-centered programs, etc)
have significantly higher developmental functions as compared to those with
late detection and intervention. There is a general agreement that a neonatal
hearing screening program should be implemented so hearing impaired baby
could be detected as early in life as possible and the rehabilitation process
can take full advantage of the auditory plasticity of the developing sensory
system.
Universal neonatal hearing screening program is the current standard
practice in developed countries to detect hearing impairment among children
at early age. The American Academy of Pediatrics supports the statement of
the Joint Committee on Infant Hearing (1994), which endorses the goal of
universal detection of hearing loss in neonates before 3 months of age, with
appropriate intervention no later than 6 months of age.
In Malaysia, the high risk neonatal hearing screening program
(HRNHS) has been introduced to the state government hospitals since 2001.
To date, 30 hospitals have started this program and more will follow suit in the
near future. To standardize the implementation activities, this guideline was
established as a guide to all the healthcare professionals involved in the
screening program at every level.
7
Buku NHS Edition:Layout 1
10/16/09
3:11 PM
Page 8
Guidelines For High Risk Neonatal Hearing Screening
2.0
2.1
DEFINITIONS
Screening
The use of tests that are quick and easy to administer to a large group
of people for the purpose of identifying individuals who require further
diagnostic testing.
2.2
Neonate
2.3
High Risk Register
A baby from birth to four weeks of age.
A list of factors that place a neonate or an infant at risk for hearing
loss. Also known as a high-risk hearing register (HRHR)(Appendix 1).
2.4
High Risk Neonatal Hearing Screening (HRNHS)
A hearing screening done to neonates who are born with high risk
factors associated with congenital or acquired hearing loss.
3.0
3.1
OBJECTIVES
General Objective
To minimize or prevent the effects of hearing impairment among high
risk neonates.
3.2
Specific Objectives
•
•
8
To detect hearing impairment ideally by 3 months of age.
To implement intervention ideally by 6 months of age.
Buku NHS Edition:Layout 1
10/16/09
3:11 PM
Page 9
Guidelines For High Risk Neonatal Hearing Screening
ROLES AND RESPONSIBILITIES
4.0
The HRNHS program involves a multi-disciplinary team of
professionals. All team members must work together to ensure the success
of the program. The roles and responsibilities of each team member should
be well defined. The team members are:
Hospital Director;
Otolaryngologists;
➢
Pediatricians;
➢
Obstetricians;
➢
Family Medicine Specialist;
➢
Audiologists;
➢
Speech language therapist;
➢
Screening personnel;
➢
Medical social worker
➢
➢
4.1
Hospital Director
4.1.1
Advisor to the screening program
4.1.2
Provides support in terms of resources:
o
Manpower
•
•
•
o
•
Screening Personnel (Staff Nurse, Assistant Medical
Officer, Technician, certified health personnel)
Audiologists
Speech Language Therapist
Health Care Assistant (Pembantu Perawatan Kesihatan)
Materials
•
Health education (e.g. brochures, pamphlets, posters,
electronic Information about hearing screening and
hearing development)
9
Buku NHS Edition:Layout 1
10/16/09
3:11 PM
Page 10
Guidelines For High Risk Neonatal Hearing Screening
o
o
4.2
Equipment & consumables
Space for hearing screening
Otorhinolaryngologist
4.2.1
Collaborates with other clinical disciplines in terms of
4.2.2
The clinician whose specialty includes determining the aetiology
comprehensive patient management.
of hearing loss, identifying related risk indicators for hearing
loss, including syndromes that involve the head and neck, and
evaluating and treating ear diseases.
4.2.3
4.2.4
An otorhinolaryngologist will determine the appropriate choice
of medical and/or surgical intervention.
When medical and/or surgical intervention is provided, the
otorhinolaringologist is involved in the long-term monitoring
and follow-up.
4.2.5
Provides information and participates in the assessment of
candidacy for amplification, assistive devices, and surgical
intervention, including reconstruction, bone-anchored hearing
aids, and cochlear implantation.
4.3
10
Paediatrician
4.3.1
To identify the babies who are at high risk of hearing loss and
4.3.2
To monitor the hearing and speech development of the baby at
initiate appropriate screening and referrals.
risk.
Buku NHS Edition:Layout 1
10/16/09
3:11 PM
Page 11
Guidelines For High Risk Neonatal Hearing Screening
4.3.3
4.3.4
4.3.5
4.4
To ensure and support the continuum of audiological
assessment and care.
To initiate referrals for medical specialty evaluations necessary
to determine the presence and etiology of the hearing loss.
To determine any other associated medical conditions.
Family Medicine Specialist / Primary Healthcare Personnel
4.4.1
4.4.2
To monitor the general health, development, and well-being of
the infant.
To review medical and family history during antenatal visits for
the presence of risk indicators that may require earlier referral.
4.4.3
To ensure and support the continuity of audiological
4.4.4
To initiate referrals for medical specialty evaluations necessary
assessment and care.
to determine the presence and aetiology of the hearing loss.
4.4.5
To monitor hearing development at 6, 12, & 18 months of age.
4.4.6
To monitor speech development at 18 months of age.
4.4.7
To counsel patients or parents.
4.4.8
To include hearing loss awareness in the maternal child health
program.
11
Buku NHS Edition:Layout 1
10/16/09
3:11 PM
Page 12
Guidelines For High Risk Neonatal Hearing Screening
4.5
Obstetrician
4.5.1
Prenatal counseling and antenatal identification of patients with
4.5.2
To ensure that all high risk newborns are included in the high
4.5.3
4.5.4
4.5.5
4.6
risk factors.
risk neonatal hearing screening program.
To ensure all newborns are included in the universal neonatal
hearing screening program when available.
To include hearing loss awareness in the maternal child health
program.
To counsel patients or parents.
Audiologist
4.6.1
To coordinate hearing screening programme development,
4.6.2
To provide audiological diagnosis, treatment and management
4.6.3
4.6.4
4.6.5
management, quality assessment and service coordination.
including appropriate referral and documentation.
To provide comprehensive audiologic diagnosis assessment
to confirm the existence of the hearing loss.
To inform the parents regarding the hearing screening result,
impact of the hearing loss and rehabilitation.
To evaluate the infant before selecting him/her as a candidate
for amplification, other sensory devices and assistive
technology and ensure prompt referral for early intervention
programs.
12
Buku NHS Edition:Layout 1
10/16/09
3:11 PM
Page 13
Guidelines For High Risk Neonatal Hearing Screening
4.6.6
To provide timely fitting and monitoring of amplification.
4.6.7
To ensure that hearing-screening information is transmitted
promptly to the primary healthcare facility and appropriate data
are submitted to the screening committee.
4.7
Speech language therapist
4.7.1
4.7.2
To provide information to parents on normal language
development.
To administer ongoing formal and informal diagnostic
assessment, to develop individualized therapy plans, to
monitor progress and to evaluate the effectiveness of the plan
for the child and family.
4.7.3
To guide and coach parents to become the primary facilitators
of their child’s listening and spoken language through active
consistent participation in individualized therapy sessions.
4.7.4
To guide and coach parents to help the child integrate listening
and spoken language into all aspects of the child’s life, by
creating environments that support listening for the acquisition
of spoken language through the child’s daily activities to
ensure comprehensive speech & language therapy.
4.7.5
4.8
To coordinate and facilitate parents’ support group activities.
Screening personnel
4.8.1
Any paramedic, who has undergone proper training in
neonatal hearing screening program, knowledgeable about
neonatal hearing screening program, hearing screening
technology and techniques of hearing screening.
13
Buku NHS Edition:Layout 1
10/16/09
3:11 PM
Page 14
Guidelines For High Risk Neonatal Hearing Screening
4.8.2
To conduct hearing screening procedure according to the
hearing screening protocols (Appendix 2 and Appendix 3) and
Infection Control Protocol.
4.8.3
To ensure that parents and primary health care professionals
receive and understand the hearing-screening results and
provide documentation.
4.8.4
4.8.5
To key in patient’s information in Hearing Screening Database
for patient’s tracking and program’s monitoring.
To provide parents with appropriate follow-up and resource
information, and that each infant is linked to a Primary
Healthcare Facility.
4.8.6
4.8.7
4.9
To consult with coordinator in ordering supplies and brochures
for screening.
To schedule the follow-up appointment prior to discharge
(neonates who are referred for hearing screening).
Medical social worker
4.9.1
To provide social, emotional and financial support to parents
whose baby have been confirmed with hearing impairment
including purchasing, fund application or rental of hearing aids.
4.9.2
14
To serve as a liaison with Welfare Department when more
financial support is required.
Buku NHS Edition:Layout 1
10/16/09
3:11 PM
Page 15
Guidelines For High Risk Neonatal Hearing Screening
5.0
5.1
METHODOLOGY
To implement the HRNHS program, the hospital should take into
consideration:
•
•
•
•
•
Screening protocols, including the timing of screening in relative
to nursery discharge;
Availability of qualified screening personnel;
Room
availability
environments;
with
good
acoustical
and
electrical
Follow-up referral criteria and referral pathways for follow-up;
•
Availability of a computer system for information management;
•
Continuous Quality Improvement
•
5.2
The availability of Auditory Brainstem Response / ABR machine;
Appropriate data collection and reporting;
Test criteria:
5.2.1
•
5.2.2
•
5.2.3
•
5.2.4
•
Subjects
All neonates born with high risk factors preferably prior to
hospital discharge.
Technology used:
ABR machine - Automated or operator-controlled machine.
One Stage screening is used
Hearing screening done by using ABR only at first stage.
Test time :
Testing time takes about 15-20 minutes, (the time maybe
longer if a baby is restless and does not include time for
discussion and preparation before test).
5.2.5
Pass/Refer criteria
15
Buku NHS Edition:Layout 1
10/16/09
3:11 PM
Page 16
Guidelines For High Risk Neonatal Hearing Screening
•
•
Pass:
- Reliable evoked response is present at ≤35 dBnHL for both
ears.
Refer:
- Reliable evoked response is absent at ≤35 dBnHL from
either ear.
5.2.6
No excessive earwax occluding the ear canals
5.2.7
Baby’s condition
•
•
Baby should be stable with no life support, no nasal cannula
and no isolette (preferably open crib).
For critically ill babies, they may require long term
hospitalization. If the hospitalization is more than 3 months,
the baby should be referred directly to the audiologist for
•
5.2.8
•
5.2.9
•
16
screening.
Screening should be done while baby is quiet (or sleeping),
well fed and comfortable.
Place for screening
Screening should be done in a quiet room with less electrical
appliances.
Equipment calibration
Screening equipment must be calibrated daily and annually.
Buku NHS Edition:Layout 1
10/16/09
3:11 PM
Page 17
Guidelines For High Risk Neonatal Hearing Screening
6.0
TRAINING FOR SCREENING PERSONNEL
6.1
The trainer
6.2
The trainee can be
•
•
Staff nurse,
•
technicians,
•
•
•
6.3
Audiologist in each hospital
Assistant Medical Officer ,
health care assistants and
volunteers.
The components of training program include:
6.3.1
Introduction of neonatal hearing screening
6.3.3
Training on how to use OAE and ABR machine
6.3.2
6.3.4
6.3.5
6.3.6
6.3.7
6.3.8
6.3.9
6.4
Trouble shooting
Handling of the baby during the test
Appropriate environment, place and time to run the screening
program
Teaching on result interpretation
Practical sessions
Documentation
The training program will be done in 2 approaches:
i.
ii.
6.5
Basics of OAE and ABR testing
Theory – 2 days
Practical under supervision for minimum 50 babies for each
trainee
Close monitoring by audiologist for 1 month after completing the
training
17
Buku NHS Edition:Layout 1
10/16/09
3:11 PM
Page 18
Guidelines For High Risk Neonatal Hearing Screening
7.0
7.1
MANAGEMENT
When there is a PASS RESULT:
•
•
The baby’s hearing is adequate for normal speech and language
development.
Ongoing monitoring and evaluation is needed when baby is born
with high risk factors (Appendix 1). This ongoing monitoring
should be done by Family Health Physician or Medical Officer in
hospitals and Health Clinics.
7.2
When there is a REFER RESULT:
•
•
The baby needs further audiological evaluation to determine
whether the baby’s hearing status is adequate for normal speech
and language development.
The abnormal result of the screening is shared with the family
before discharge, and appointment for further evaluation is
scheduled by the Screening Personnel and/or Audiologist.
7.3
When there is a MISSED SCREEN:
•
7.4
The babies will undergo re-screening with an audiologist within 7
days after discharge.
Surveillance and screening in the primary healthcare facility
7.4.1
For all babies, regular surveillance of developmental
milestones, auditory skill, parental concerns and speech and
language development should be performed in the primary
healthcare facility.
18
Buku NHS Edition:Layout 1
10/16/09
3:11 PM
Page 19
Guidelines For High Risk Neonatal Hearing Screening
7.4.2
Babies who do not follow normal development milestone or for
whom there is a concern on hearing or language development
should be referred for speech-language evaluation and/or
audiology assessment.
8.0
8.1
8.2
PROGRAM EVALUATION AND MONITORING
All post screening data should be entered into ORL registry; Hearing
Screening Database.
Program coordinator (audiologist) from each hospital should evaluate
the program 3 monthly based on the quality indicators and the
benchmarks as below.
8.3
The Quality Indicators for high risk neonatal hearing screening
8.3.1
8.3.2
8.3.3
8.3.4
Percentage of neonates screened before three months of age.
Percentage of neonates who do not pass the birth admission
screening.
Percentage of neonates who do not pass the screening and
referred for audiological and medical evaluation.
Percentage of neonates who return for follow up services
(either audiological or medical evaluation).
8.3.5
Percentage of babies who fail hearing screening and confirm
8.3.6
Percentage of families who refuse hearing screening on birth
8.3.7
with hearing loss before 6 months of age.
admission.
Age of the babies when intervention is undertaken (e.g.
hearing aid fitting and speech therapy).
19
Buku NHS Edition:Layout 1
10/16/09
3:11 PM
Page 20
Guidelines For High Risk Neonatal Hearing Screening
8.4
Benchmarks for High Risk Neonatal Hearing Screening programme
(based on KPI: High Risk Neonate Hearing Screening for early
detection and intervention 2007 by Jawatankuasa Kecil Teknikal
Pegawai Pemulihan Perubatan Pendengaran).
8.4.1
Percentage of neonates underwent hearing screening should
8.4.2
Referral rate for follow-up following failure in hearing screening
8.4.3
20
be ≥ 95%.
should ≤ 4%.
Percentage of neonates who return for follow up services
(either audiological and medical evaluation) should be ≥ 70%.
Buku NHS Edition:Layout 1
10/16/09
3:11 PM
Page 21
Guidelines For High Risk Neonatal Hearing Screening
APPENDIX 1
HIGH RISK REGISTER
A.
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
B.
1.
2.
3.
4.
For use with NEONATE
Family history of hereditary childhood sensorineural hearing loss
In-utero infection, such as cytomegalovirus, rubella, syphilis, herpes and
toxoplasmosis
Craniofacial anomalies including those with morphological abnormalities
of the pinna and ear canal
Birth weight less than 1,500 grams (1.5 kg)
Hyperbilirubinemia at a serum level requiring exchange transfusion
Ototoxic medications, including but not limited to the amino glycosides,
used in multiple courses or in combination with loop diuretics
Bacterial meningitis
APGAR scores of 0 – 4 at 1 minute or 0 – 6 at 5 minutes
Mechanical ventilation lasting 5 days or longer
Stigmata or other findings associated with a syndrome known to include a
sensorineural and/or conductive hearing loss
For use with BABIES (age 29 days through 2 years) when certain
health conditions which require re-screening
Parents or caregiver concerns regarding hearing, speech, language, or
developmental delay
Bacterial meningitis and other infections associated with sensorineural
hearing loss
Head trauma associated with loss of consciousness or skull fracture
Stigmata or other findings associated with a syndrome known to include a
sensorineural and/or conductive hearing loss
21
Buku NHS Edition:Layout 1
10/16/09
3:11 PM
Page 22
Guidelines For High Risk Neonatal Hearing Screening
5.
Ototoxic medications, including but not limited to chemotherapeutic agent
or amino-glycosides, used in multiple courses or in combination with loop
diuretics
6.
Recurrent or persistent otitis media with effusion for at least 3 months
C.
For use with BABIES (age 29 days through 3 years) who require
periodic monitoring of hearing.
Some newborns and infants may pass initial hearing screening but require
periodic monitoring of hearing to detect delayed-onset sensorineural and/or
conductive hearing loss. Babies with these indicators require hearing
evaluation at least every 6 months until 3 years, and at appropriate intervals
thereafter.
Indicators associated with delayed onset sensorineural hearing loss
include:
1.
2.
3.
Family history of hereditary childhood hearing loss.
In utero infection, such as cytomegalovirus, rubella, syphilis, herpes
and toxoplasmosis.
Neurofibromatosis Type II and neurodegenerative disorders.
Indicators associated with conductive hearing loss include:
1.
2.
3.
22
Recurrent or persistent otitis media with effusion.
Anatomic deformities and other disorders that affect Eustachian
tube function.
Neurodegenerative disorders.
Buku NHS Edition:Layout 1
10/16/09
3:11 PM
Page 23
Guidelines For High Risk Neonatal Hearing Screening
APPENDIX 2
FLOWCHART FOR HIGH RISK NEONATAL HEARING SCREENING
High Risk
Baby
Screening
ABR
PASS
Follow-up at
primary health
care
REFER
Normal
hearing
Diagnostic
OAE & ABR
Confirm
Hearing
loss
Intervention
23
Buku NHS Edition:Layout 1
10/16/09
3:11 PM
Page 24
Guidelines For High Risk Neonatal Hearing Screening
APPENDIX 3
WORK PROCESS OF HIGH RISK NEONATAL HEARING SCREENING
1.
2.
3.
4.
5.
6.
7.
8.
9.
Specialist/ Medical Officer of NICU, SCN, Pediatric Department or postnatal
ward identify high risk baby (based on Appendix 1) for hearing screening.
Specialist/ Medical Officers fill-up the hearing screening form (see Appendix
4) and refer to hearing screening personnel.
Screening personnel enter baby’s information in Hearing Screening
Database.
Inform the parents/caregivers about hearing screening process.
Screening personnel prepares the hearing screening equipment.
Prepare baby for the hearing screening procedure. Mothers are
encouraged to be with their baby during the procedure.
Screening process is done according to Appendix 2 and Appendix 3.
Screening personnel informs the result to parents/caregivers and records
all results obtained in the Hearing Screening Database.
For babies with pass result but have high risk factors associated with late-
onset, progressive, or fluctuating hearing loss; ongoing medical, hearing
and communication development monitoring should be done in primary
10.
11.
12.
health care during immunization follow-up.
For babies with refer result, appointment date for audiological diagnostic
assessment will be given to the parents. Appointment date should be within
6 to 8 weeks, or no later than 3 months of age.
Audiological diagnostic assessment will be done in audiology clinic by
appointment.
For babies with normal hearing; hearing and communication development
monitoring should be done in primary health care facilities during
immunization follow-ups.
24
Buku NHS Edition:Layout 1
10/16/09
3:11 PM
Page 25
Guidelines For High Risk Neonatal Hearing Screening
13.
For babies with confirm hearing loss; further audiological, speech and
14.
Audiological interventions includes hearing aids fitting, auditory training and
15.
Speech interventions should include speech and language therapy.
16.
17.
medical intervention will be given immediately.
periodic follow-ups.
Medical interventions should include medical diagnosis and direction for
medical and/or surgical treatment options for hearing loss and/or related
medical disorder(s) associated with hearing loss.
For transferred cases, screening personnel shall take note and refer them
to the preferred hospital for further medical evaluation and/or audiological
diagnostic assessment.
25
Buku NHS Edition:Layout 1
10/16/09
3:11 PM
Page 26
Guidelines For High Risk Neonatal Hearing Screening
APPENDIX 4
HIGH RISK NEONATAL HEARING SCREENING FORM
B/O :
IC/passport (M):
DOB :
Phone No.:
Risk factors
Risk factors
Family history*
Parental concern*
Ventilation > 5 days
Ototoxic medication
Hyperbilirubinemia *
In-utero infection (CMV*)
Craniofacial anomalies
Associated syndrome*
Neurodegenerative disorders
Meningitis*
Head trauma
APGAR scores of 0 – 4 at 1
minute or 0 – 6 at 5 minutes
Very low birth weight (< 1.5 kg)
* Risk indicators that are marked with an asterisk are of greater concern for delayed-onset hearing
loss. Please refer to audiologist after screening
Signature
Name of Medical Officer
(NICU ward/ pediatric clinic)
To be filled by screener
Parents consent: YES / NO
Auditory Brainstem Response (ABR) testing:
PASS
REFER
Right ear
Left ear
Name and signature:
Date:
• carbonized and standardized (2 copies)
26
Buku NHS Edition:Layout 1
10/16/09
3:11 PM
Page 27
Guidelines For High Risk Neonatal Hearing Screening
9.0
1.
2.
REFERENCES
National Institute of Health (NIH) Concensus Statement, 1993.
Joint Committee of Infant Hearing, Position Statement 1994
3.
Health Technology Assessment Report; Screening For Hearing Loss
4.
Pediatrics, 120(4), pp. 898–921.Joint Committee of Infant Hearing,
5.
6.
7.
8.
9.
in Infants, ,2004
Position Statement 2007
ASHA guideline 1996; Guidelines for Audiologic Screening
Mehl AL, Thomson V. Newborn hearing screening: great omission.
Pediatrics 1998;101:E4
Meh AL, Thomson V. The Colorado newborn hearing screening
project, 1992-1999: On the threshold of effective population-based
universal newborn hearing screening. Pedaitrics 2002;109:E7
Thompson DC, McPhillips H, Davis RL, Lieu TL, Homer CJ, Helfand
M, Universal Newborn hearing screening : summary of evidence.
JAMA 2001; 286:2000-10
Davis A, Bamford J, Wilson I, Ramkalwan T, Forshaw M. Wright S.A
critical review of the role of neonatal hearing screening in detection of
congenital hearing impairment. Health Technology Assessment
10.
11.
12.
13.
1997;1. http://hta.nhsweb.nhs.uk (cited 2002 Sept 19)
Harvey Coates, Kim Gifkins. Diagnostic Test: Newborn hearing
screening. Australian Prescriber Vol. 26 No.4 2003
Colorado Infant Hearing Advisory Committee Guidelines for Infant
Hearing Screening, Audiological Assessment, and Intervention;
December 14, 2000
AAP, Task Force on Newborn and Infant Hearing; Newborn and
Infant Hearing Loss: Detection and Intervention. Pediatrics.
1999;103:527-530
Bio-logic, Impementation of Early Hearing Detection and Intervention-
EHDI.2001
27
Buku NHS Edition:Layout 1
10/16/09
3:11 PM
Page 28
Guidelines For High Risk Neonatal Hearing Screening
DRAFTING COMMITTEE
ADVISORS
Datuk Dr. Noor Hisham B Abdullah
Deputy Director General of Health (Medical)
Ministry of Health Malaysia
Dato’ Dr Hj Azmi B. Shapie
Director
Medical Development Division
Ministry of Health Malaysia
Dr. Teng Seng Chong
Senior Deputy Director
Medical Development Division
Ministry of Health Malaysia
COORDINATOR
Mr. Abd Majid B. Md Nasir
Head of Department
Otorhinolaringology Department
Hospital Kuala Lumpur
28
Buku NHS Edition:Layout 1
10/16/09
3:11 PM
Page 29
Guidelines For High Risk Neonatal Hearing Screening
SECRETARIAT
Dr Patimah Bt. Amin
Senior Principal Director
Surgical And Emergency Medicine Services Unit
Medical Development Division
Ministry of Health Malaysia
Dr Thatcheiany Kumariah
Assisstant Director
Surgical And Emergency Medicine Services Unit
Medical Development Division
Ministry of Health Malaysia
Dr. Muhammed Anis B. Abd Wahab
Assisstant Director
Transplant Unit
Medical Development Division
Ministry of Health Malaysia
29
Buku NHS Edition:Layout 1
10/16/09
3:11 PM
Page 30
Guidelines For High Risk Neonatal Hearing Screening
MEMBERS
Wan Suhailah Bt Wan Husain
Audiologist
Hospital Sultanah Nur Zahirah, Kuala Terengganu
Pn Yusmeera Bt Yusoff
Audiologist
Hospital Kuala Lumpur
Dr Irene Cheah
Paediatrician
Institute Paediatric
Hospital Kuala Lumpur
Dr Chee Seok Chiong
Neonatologist
Hospital Kuala Lumpur
Prof Siti Zamratol-Mai Sarah Bt Mukari
Deputy Dean
Faculty of Allied Health Sciences
Universiti Kebangsaan Malaysia
Dr Hussain Imam B. Hj Mohammad Ismail
Head of Department & Consultant
Institute Pediatric
Hospital Kuala Lumpur
30
Buku NHS Edition:Layout 1
10/16/09
3:11 PM
Page 31
Guidelines For High Risk Neonatal Hearing Screening
Dr. K. Mukudan
O&G National Advisor
O&G Department
Hospital Raja Permaisuri Bainun, Ipoh
Puan Bibi Florina Abdullah
Director of Nursing
Nursing Division
Ainul Naquiah Bt Mad Nordin
Audiologist
Hospital Serdang
Nurul Ain Bt. Abdullah
Audiologist
Hospital Kuala Lumpur
Norasuzi Bt Abd Halim
Audiologist
Hospital Sultanah Bahiyah, Alor Setar
Hanita Bt Hashim
Audiologist
Hospital Ampang
Zaidi B. Ya’acob
Speech and Language Therapist
Hospital Kuala Lumpur
31
Buku NHS Edition:Layout 1
10/16/09
3:11 PM
Page 32
Guidelines For High Risk Neonatal Hearing Screening
Dr Salimah Othman
Principal Assistant Director
Family Health Development
Ministry of Health
Dr Rafidah Mazlan
Audiologist/Lecturer
Faculty of Allied Health Sciences
Universiti Kebangsaan Malaysia
Suzana Bt Mansor
Audiologist
Hospital Universiti Sains Malaysia
Siti Hufaidah Bt Konting
Audiologist
Pusat Perubatan Universiti Malaya
Marina Lamri Alisaputri
Audiologist
Universiti Islam Antarabangsa
32